Skip to main content
179 results:
22. Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients  
SphingoTec GmbH (“SphingoTec”) announced today that the Acute Disease Quality Initiative (ADQI) recommends the use of novel biomarkers for AKI, including functional biomarkers as penKid®.  
23. Resource Center  
Scientific Publications Browse our scientific publications to learn more about how our biomarkers can impact patient care. Learn more Downloads Discover our brochures, product cataloge and white…  
24. Collaborations  
SphingoTec is collaborating with leading hospitals in Europe, the US, and Asia, a growing network of distribution partners, global IVD companies (out-licensing) and pharmaceutical companies…  
25. Service Measurements  
On the basis of optimized protocols, we provide reliable services for competitive prices. Below you will find the full MTP biomarker assay range: Get in touch with us Do you have any questions…  
26. Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise  
The Uniklinik RWTH Aachen (“Uniklinik RWTH Aachen”) has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH (“SphingoTec”) into clinical routine.   
27. Company  
Team We know great work begins with great people. Our skilled international team has a breadth of experience in life sciences, biotechnology, and the clinical diagnostics and laboratory…  
29. Science  
Critical care settings SphingoTec identified major pathways driving mortality in critical care and has developed specific biomarkers predicting, diagnosing and monitoring these major mortality…  
Search results 21 until 30 of 179